Catarina Martins da Costa

ORCID: 0000-0003-3313-7735
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Structural Anomalies and Repair
  • Cardiomyopathy and Myosin Studies
  • Cardiac Arrhythmias and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Transplantation: Methods and Outcomes
  • Genetic Neurodegenerative Diseases
  • Cardiovascular and Diving-Related Complications
  • Cardiac tumors and thrombi
  • Atrial Fibrillation Management and Outcomes
  • Trauma Management and Diagnosis
  • Cardiovascular Function and Risk Factors
  • Infective Endocarditis Diagnosis and Management
  • Lymphoma Diagnosis and Treatment
  • Muscle Physiology and Disorders
  • Congenital Heart Disease Studies
  • Viral Infections and Immunology Research
  • Cardiac Valve Diseases and Treatments
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Renal Transplantation Outcomes and Treatments

Universidade do Porto
2023-2024

Hospital de São João
2023-2024

ERN GUARD-Heart
2023

Cardiac magnetic resonance (CMR) is an established tool for risk stratification in several cardiomyopathies, and its role muscular dystrophies (MuD) looks promising. We sought to assess how CMR performs predicting cardiac events a real cohort of MuD patients. A prospective single-center study with the enrollment consecutive adult patients referred screening from 2012 2018 collection clinical data. During follow-up (FUP), major adverse were considered composite device implantation,...

10.4081/monaldi.2024.2851 article EN cc-by-nc Monaldi Archives for Chest Disease 2024-02-02

Percutaneous closure of the patent foramen ovale (PFO) is increasingly performed in specific patients with cryptogenic stroke or clinical evidence a paradoxical embolism. This study was to determine safety same-day discharge (SDD) following such procedures. prospective, observational undergoing elective percutaneous PFO single tertiary center Portugal between January 2020 and July 2023. AmplatzerTM devices (St. Jude Medical, St. Paul, MN, USA) NobblestichTM EL (HeartStitch, Inc., Fountain...

10.4081/monaldi.2024.2833 article EN cc-by-nc Monaldi Archives for Chest Disease 2024-02-02

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Recently, a connection has been observed between presence of first-degree atrioventricular block (FDAVB) and cardiovascular outcomes, although pathophysiology this association remains poorly understood. Considering period 2000-2023, we retrospectively included HCM patients at sinus rhythm first appointment sought possible interactions FDAVB (defined as PR interval >200 ms) with different clinical imaging...

10.4081/monaldi.2024.2860 article EN cc-by-nc Monaldi Archives for Chest Disease 2024-03-06

Percutaneous mitral valve commissurotomy (PMC) is a viable alternative to (MV) surgery in the treatment of patients with rheumatic stenosis (RMS). In this single-center retrospective study consecutive RMS submitted PMC from 1991 2008, we analyzed clinical, echocardiographic, and hemodynamic data events during follow-up (FUP) until December 2021. Major adverse cardiovascular (MACE) were combined endpoint all-cause death, hospitalization, MV re-intervention. A total 124 enrolled: 108 (87.1%)...

10.4081/monaldi.2024.2941 article EN cc-by-nc Monaldi Archives for Chest Disease 2024-03-11

Abstract Background and Aim: Pulmonary regurgitation is the most common complication in repaired tetralogy of Fallot patients. Severe chronic pulmonary can be tolerated for decades, but if not treated, it progress to symptomatic, irreversible right ventricular dilatation dysfunction. We investigated clinical associations with valve replacement among patients significative how interventional developments change their management. Methods: All adult who were followed at an CHD Clinic a single...

10.1017/s1047951123003608 article EN Cardiology in the Young 2023-11-03
Coming Soon ...